Annual Net Income
-$60.63 M
-$39.38 M-185.33%
31 March 2024
Summary:
LakeShore Biopharma annual net profit is currently -$60.63 million, with the most recent change of -$39.38 million (-185.33%) on 31 March 2024. During the last 3 years, it has fallen by -$32.32 million (-114.14%). LSB annual net income is now -267.41% below its all-time high of -$16.50 million, reached on 01 March 2022.LSB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$14.51 M
-$4.58 M-46.21%
30 September 2023
Summary:
LakeShore Biopharma quarterly net profit is currently -$14.51 million, with the most recent change of -$4.58 million (-46.21%) on 30 September 2023. LSB quarterly net income is now -1273.63% below its all-time high of $1.24 million, reached on 01 September 2022.LSB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$24.43 M
-$15.74 M-181.24%
30 September 2023
Summary:
LakeShore Biopharma TTM net profit is currently -$24.43 million, with the most recent change of -$15.74 million (-181.24%) on 30 September 2023. LSB TTM net income is now -1313.84% below its all-time high of -$1.73 million, reached on 01 September 2022.LSB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -185.3% | - | - |
3 y3 years | -114.1% | - | - |
5 y5 years | - | - | - |
LSB Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -267.4% | at low | -1273.6% | at low | -1313.8% | at low |
5 y | 5 years | -267.4% | at low | -1273.6% | at low | -1313.8% | at low |
alltime | all time | -267.4% | at low | -1273.6% | at low | -1313.8% | at low |
LakeShore Biopharma Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | -$60.63 M(+185.3%) | - | - |
Sept 2023 | - | -$14.51 M(+46.2%) | -$24.43 M(+181.2%) |
June 2023 | - | -$9.92 M(-902.7%) | -$8.69 M(+402.7%) |
Mar 2023 | -$21.25 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2022 | - | $1.24 M(-141.7%) | -$1.73 M(-41.7%) |
June 2022 | - | -$2.96 M | -$2.96 M |
Mar 2022 | -$16.50 M(-41.7%) | - | - |
Mar 2021 | -$28.31 M | - | - |
FAQ
- What is LakeShore Biopharma annual net profit?
- What is the all time high annual net income for LakeShore Biopharma?
- What is LakeShore Biopharma annual net income year-on-year change?
- What is LakeShore Biopharma quarterly net profit?
- What is the all time high quarterly net income for LakeShore Biopharma?
- What is LakeShore Biopharma TTM net profit?
- What is the all time high TTM net income for LakeShore Biopharma?
What is LakeShore Biopharma annual net profit?
The current annual net income of LSB is -$60.63 M
What is the all time high annual net income for LakeShore Biopharma?
LakeShore Biopharma all-time high annual net profit is -$16.50 M
What is LakeShore Biopharma annual net income year-on-year change?
Over the past year, LSB annual net profit has changed by -$39.38 M (-185.33%)
What is LakeShore Biopharma quarterly net profit?
The current quarterly net income of LSB is -$14.51 M
What is the all time high quarterly net income for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly net profit is $1.24 M
What is LakeShore Biopharma TTM net profit?
The current TTM net income of LSB is -$24.43 M
What is the all time high TTM net income for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM net profit is -$1.73 M